Shopping Cart
- Remove All
Your shopping cart is currently empty
AZ1495 is an oral active inhibitor of Interleukin-1 receptor associated kinase 4 (IRAK4), with IC50 values of 5 nM and 23 nM for IRAK4 and IRAK1, respectively. Which Shows activity in treatment of mutant MYD88L265P diffuse large B-cell lymphoma (DLBCL).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $89 | In Stock | |
| 5 mg | $167 | In Stock | |
| 10 mg | $273 | In Stock | |
| 25 mg | $388 | In Stock | |
| 50 mg | $548 | In Stock | |
| 100 mg | $833 | In Stock | |
| 200 mg | $1,120 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $188 | In Stock |
| Description | AZ1495 is an oral active inhibitor of Interleukin-1 receptor associated kinase 4 (IRAK4), with IC50 values of 5 nM and 23 nM for IRAK4 and IRAK1, respectively. Which Shows activity in treatment of mutant MYD88L265P diffuse large B-cell lymphoma (DLBCL). |
| Targets&IC50 | Haspin:4 nM, CLK2:5 nM, IRAK4:5 nM, IRAK1:23 nM, CLK4:8 nM, CLK1:50 nM |
| Molecular Weight | 385.5 |
| Formula | C21H31N5O2 |
| Cas No. | 2196204-23-4 |
| Smiles | C1CC(CCO1)c1c[nH]c2ncnc(N[C@H]3CC[C@@H](CC3)N3CCOCC3)c12 |
| Relative Density. | 1.265 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 10 mg/mL (25.94 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.